Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Journal of Neuroimmunology|December 14, 2004
Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosisF Gilli, F Marnetto, M Caldano, et al.Neuroscience Letters|April 28, 1999
Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patientsA Bertolotto, M Capobianco, S Malucchi, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 18, 2004
Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodiesA Bertolotto, A Sala, S Malucchi, et al.Neurology|October 31, 2008
Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosisF Gilli, P Valentino, M Caldano, et al.Neurology|February 15, 2008
Predictive markers for response to interferon therapy in patients with multiple sclerosisS Malucchi, F Gilli, M Caldano, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 18, 2002
Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratoryA Bertolotto, S Malucchi, A Sala, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 11, 2007
Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease)M Capobianco, S Malucchi, A di Sapio, et al.Multiple Sclerosis and Related Disorders|July 23, 2023
Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patientsP Valentino, S Malucchi, C I Bava, et al.Cytokine & Growth Factor Reviews|January 19, 2015
Biological monitoring of IFN-β therapy in Multiple SclerosisA Bertolotto, L Granieri, F Marnetto, et al.Multiple Sclerosis and Related Disorders|January 10, 2024
Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patientsD Vecchio, C Puricelli, S Malucchi, et al.Pageof 3